mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability.

Volume: 601, Pages: 120586 - 120586
Published: May 15, 2021
Abstract
A drawback of the current mRNA-lipid nanoparticle (LNP) COVID-19 vaccines is that they have to be stored at (ultra)low temperatures. Understanding the root cause of the instability of these vaccines may help to rationally improve mRNA-LNP product stability and thereby ease the temperature conditions for storage. In this review we discuss proposed structures of mRNA-LNPs, factors that impact mRNA-LNP stability and strategies to optimize mRNA-LNP...
Paper Details
Title
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability.
Published Date
May 15, 2021
Volume
601
Pages
120586 - 120586
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.